Profile

Medpace Holdings, Inc. is a midsize, clinical contract research organization based in Cincinnati, Ohio. It provides services for Phase I-IV of drug and medical device development services including regulatory services and central laboratory services. The company started trading stock as a public firm in 2016. Dr. August Troendle founded Medpace in Cincinnati, Ohio in 1992 as Medical Rearch Services. Dr. Troendle first became interested in the CRO sector after working in both the regulatory and pharmaceutical area. He began his career as a reviewer with the FDA, specializing in the development of lipid lowering therapies to treat high cholesterol.